Inner Banner

2021

breadCrumb

Submitted by admin on Thu, 02/22/2024 - 13:38
  • Chaudhari P. (2021). Preclinical Imaging of Laboratory Rodents. In Nagarajan P, Ramachandra SG, Suresh R (Eds) Essentials of Laboratory Animal Science: Principles and Practices.  Singapore; Springer, 2021. Pp 607-630. (ISBN 978-981-16-0987-9)

Submitted by admin on Mon, 01/17/2022 - 16:08
  1. Bhattacharjee A. Bayesian Approches in Oncology Using R and OpenBUGS. 1st ed. Florida: CRC Press, 2021. (ISBN: 978-0-367-35050-5)
  2. Pujar SM, Munnolli SS, Babu R (Eds.) Open Scholarship and Libraries, Sunstar Publishers: Banglore, 2021.

Submitted by admin on Fri, 03/19/2021 - 15:37
  1. Kulkarni P, Mehta P, Shriyan B, Gawit K, Gota V, Ghante M. (2021) "Pharmacokinetics, Pharmacodynamics, and Toxicology Aspects of Immunotherapeutics". In: Sawarkar SP, Nikam VS, Syed S. (Eds.) Immunotherapy – A Novel Facet of Modern Therapeutics. Singapore Springer, 2021. Pp. 195-214. (ISBN: 978-981-15-9037-5)
  2. Thorat R. "Assisted Reproductive Technologies (ARTs) in the Laboratory Mouse. In: Nagarajan P, Gudde R, Srinivasan R. (Ëds.) Essentials of Laboratory Animal Science: Principles and Practices. Singapore; Springer, 2021. Pp. 679-707.

Submitted by admin on Fri, 03/19/2021 - 15:37
  1. Barange M, Epari S, Gurav M, Shetty O, Sahay A, Shetty P, Goda J, Moiyadi A, Gupta T, Jalali R (2021). TERT promoter mutation in adult glioblastomas: It's correlation with other relevant molecular markers. Neurology India. 69:126-34. PMID: 33642283

  2. Lewis S, Chopra S, Singh R, Engineer R (2021). A survey of the practice of stereotactic body radiotherapy for hepatocellular and pancreatic malignancies in India. Indian Journal of Cancer. 58(4): 532-538. PMID: 33753598

Submitted by admin on Fri, 03/19/2021 - 15:22
  1. Anand D, Yashashwi K, Kumar N, Rane S, Gann PH, Sethi A (2021). Weakly supervised learning on unannotated hematoxylin and eosin stained slides predicts BRAF mutation in thyroid cancer with high accuracy. Journal of Pathology. 255(3):232-242 PMID: 34346511
  2. Anand S, Chatterjee A, Gupta T, Panda P, Moiyadi A, Epari S, Patil V, Krishnatry R, Goda JS, Jalali R (2021). Upfront therapy of aggressive/high-risk low-grade glioma: single institution outcome analysis of temozolomide-based radio-chemotherapy and adjuvant chemotherapy.
Subscribe to 2021
Back to Top